Genentech released the results of its Phase III Avastin study showing that women that take the ovarian cancer treatment in tandem with chemotherapy had a 39 percent improvement in the likelihood of living longer without the disease worsening than patients being treated with just chemotherapy.
The data was released at the annual meeting of American Society [...]
PharmExec Blog
Follow Us
RSS
Bookstore
Avastin Study Shows Promising Data for Cancer Patients